-+ 0.00%
-+ 0.00%
-+ 0.00%

TEVA ANNOUNCES U.S. FOOD AND DRUG ADMINISTRATION (FDA) APPROVAL OF WELTRUZA™ (OLANZAPINE) FOR EXTENDED-RELEASE INJECTABLE SUSPENSION, AS THE FIRST AND ONLY ONCE-MONTHLY SUBCUTANEOUS INJECTABLE OLANZAPINE FOR ADULTS WITH SCHIZOPHRENIA

路透·10/09/2026 11:00:01

请登录查看新闻详情